News by subject: Conference

Genmab A/S and BioNTech SE today announced initial data from the Phase 2 GCT1046-04 trial (NCT05117242) evaluating acasunlimab (DuoBody-PD-L1x4-1BB), an investigational bispecific antibody also known as GEN1046/BNT311, as monotherapy and in...

Ankyra Therapeutics, a clinical-stage oncology company developing anchored immunotherapies to improve the therapeutic window for immuno-oncology drugs, announced today that it is presenting a Trial in Progress poster for the phase 1 ANCHOR clinical...

Nuvation Bio Inc. , a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, announced that results from the pivotal Phase 2 TRUST-I study conducted in China evaluating taletrectinib, its...

Takeda (TSE:4502/NYSE:TAK) and Pfizer today announced that the German Hodgkin Study Group (GHSG) will present positive results from the Phase 3 HD21 trial evaluating ADCETRIS® (brentuximab vedotin) in combination with chemotherapy as a late-breaking...

Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, announced data from an ongoing Phase 1 study of AC699 monotherapy in patients with ER-positive / HER2-negative locally advanced or...

Gilead Sciences, Inc. and Arcus Biosciences, Inc. today announced longer-term efficacy and safety results from Arm A1 of the Phase 2 EDGE-Gastric study. These updated data show consistent objective response rate (ORR) and provide mature...

Pfizer Inc. today announced detailed overall survival (OS) results from the Phase 3 ECHELON-3 study of ADCETRIS® (brentuximab vedotin) in combination with lenalidomide and rituximab for the treatment of patients with relapsed/refractory diffuse...

Bristol Myers Squibb today announced results from the Phase 3 KRYSTAL-12 study evaluating KRAZATI® (adagrasib) compared to standard of care chemotherapy in patients with locally advanced or metastatic KRASG12C-mutated non-small cell lung cancer...

ASCO Annual Meeting ? Massive Bio, pioneering leader in AI-driven oncology solutions, is excited to announce the launch of its latest product, Drug Utilization Optimizer (DUO), at the upcoming ASCO Annual Meeting 2024. The innovative analytics and...

Inocras Inc., a leader in whole genome sequencing (WGS) diagnostics and precision medicine, is proud to present groundbreaking research on radiogenomics and homologous recombination deficiency (HRD) in breast cancer at the American Society of...

Summit Therapeutics Inc. ("Summit," "we," or the "Company") announced that, on May 24, 2024, our partner, Akeso Inc. (Akeso, HKEX Code: 9926.HK), received marketing authorization in China from the National Medical Products Administration (NMPA). The...

Ventas, Inc. (the "Company") announced today that management will make a presentation regarding the Company at Nareit's REITweek 2024 Investor Conference (the "Nareit Conference") on June 4, 2024 at 2:15 p.m. Eastern Time. The webcast will be...

Equity Residential today announced that members of the Company's senior management team, including the Company's President and CEO, Mark J. Parrell, will participate in a roundtable presentation at the Nareit REITweek 2024 Investor Conference on...

Camden Property Trust (the "Company") announced today that it will participate in Nareit's REITweek 2024 Investor Conference which is being held June 3-6, 2024. The Company also provided operating statistics for second quarter 2024 as detailed...

Emerald Holding, Inc. ("Emerald" or the "Company"), America's largest producer of trade shows and their associated conferences, content and commerce, today announced that the Company is scheduled to participate virtually in Maxim Group's conference...

AVALONBAY COMMUNITIES, INC. (the "Company") announced today that the Company will be participating in Nareit's REITweek Conference from June 3 ? 6, 2024. During this event, management may discuss the Company's current operating environment and...

Bruker Corporation announced today it will present at the following conferences: 2024 Jefferies Global Healthcare Conference, New York, NY Thursday, June 6, 2024, at 7:30 a.m. Eastern Time Frank Laukien, Chairman, President and Chief Executive...

Asana, Inc. (LTSE: ASAN), a leading work management platform, today announced that Asana's executives will present at the following investor events: Baird 2024 Global Consumer, Technology & Services Conference on June 4, 2024 at 8:25 a.m. PT /...

KalVista Pharmaceuticals, Inc. , today announced that late-breaking data from the pivotal phase 3 KONFIDENT trial and open label KONFIDENT-S extension trial evaluating the efficacy and safety of sebetralstat were presented as late-breaking...

Humanetics Corporation, a clinical-stage specialty pharmaceutical company developing radioprotectant drugs for warfighters and cancer patients, is presenting a corporate overview and details on its promising lead radioprotective drug candidate, BIO...

TrueBlue , a leading provider of specialized workforce solutions, today announced that Chief Executive Officer Taryn Owen and Chief Financial Officer Carl Schweihs will be attending the Baird Global Consumer Technology & Services conference on...

Stallergenes Greer, a leading global healthcare company specialising in allergen immunotherapy (AIT), hosted today a company-sponsored symposium entitled "Allergen harmony": New data for a tailored and sustained food and respiratory immunotherapy...

Marriott Vacations Worldwide Corporation announced today that Jason Marino, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 2nd Annual Travel & Leisure Conference on June 4, 2024 at...

Capstan Therapeutics, Inc. ("Capstan"), a biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted lipid nanoparticles (tLNP), today announced that company management will participate in the...

RXO today announced that Jared Weisfeld, chief strategy officer, will participate in the Wells Fargo Industrials Conference in Chicago, Illinois, on Tuesday, June 11, from 9:45 a.m. until 10:20 a.m. EDT. A live webcast and replay of the...

PagerDuty, Inc. , a global leader in digital operations management, today announced that members of its management team will present at the Bank of America Global Technology Conference 2024 on Tuesday, June 4th at 2:20 pm ET and the William Blair...

MBracetm Therapeutics, Inc. ("MBrace"), a clinical-stage oncology company developing novel antibody-drug conjugates (ADCs) against solid tumor targets, today announced that the Company will be presenting a Trial in Progress (TIP) poster at the...

nference, a company dedicated to transforming healthcare by making biomedical data computable, will present research at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4 in Chicago. The poster, titled A deep...

Gilead Sciences, Inc. today announced detailed results from the Phase 3 EVOKE-01 study that will be presented during an oral session (Abstract #LBA8500) today (2:45-5:45pm CT) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting....

Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that management will present at the 2024 BIO International Convention being held June 3-6, 2024 in San...

Pfizer Inc. today announced longer-term follow-up results from the Phase 3 CROWN trial evaluating LORBRENA® (lorlatinib, a third-generation ALK inhibitor, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people...

Quantum-Si Incorporated ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Companytm, today announced presentations at two upcoming industry conferences. Gloria Sheynkman, PhD, Assistant Professor in the Department of Molecular...

Okta, Inc. , the leading independent identity partner, today announced that Brett Tighe, Chief Financial Officer of Okta, is scheduled to participate in the following upcoming investor conference. Nasdaq Investor Conference in London, United...

Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in the following upcoming...

Agendia®, Inc. today announced it will present new data characterizing the immune biology of MammaPrint High Risk tumors in an oral session at the 2024 Annual American Society of Clinical Oncology (ASCO) Meeting, taking place in Chicago, IL. on June...

Camping World Holdings, Inc. ("Camping World"), the world's largest recreational vehicle dealer, today announced that Chairman and Chief Executive Officer Marcus Lemonis, and Chief Accounting Officer, Tom Kirn, will present at the Baird 2024 Global...

Denodo: What: Denodo, a leader in data management, is sponsoring and exhibiting at the Snowflake Data Cloud Summit 2024 (booth 1220). Denodo will showcase how the Denodo Platform, the leading logical data management platform, will seamlessly...

Warby Parker Inc. (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the TD Cowen 8th Annual Future of the Consumer Conference on Tuesday, June 4, 2024 at 2:25 p.m....

Arrowhead Pharmaceuticals, Inc. today announced that it is scheduled to participate in the following upcoming events: 16th European Glaucoma Society (EGS) Congress ? June 1-4, 2024 Title: Development and Characterization of Trabecular Meshwork...

Today, at the American Society for Clinical Oncology (ASCO) annual meeting, Mika Health, a global digital therapeutics developer specializing in meeting the needs of cancer patients, and Cancer Support Community (CSC), a recognized leader in cancer...

CloudFabrix the inventor of Robotic Data Automation Fabric Platform and the leader in Gigaom AIOps Radar report for 3 consecutive years and a value leader in several categories in Enterprise Management Associates (EMA) Radar report, is set to...

DataRobot, the enterprise AI platform leader, today announced the integration of LLM evaluation measures aligned with a new initiative from the Singapore Government Agency, Infocomm Media Development Authority (IMDA). The "Project Moonshot"...

Excelerate Energy, Inc. announced today that management will participate in the following upcoming investor conferences: J.P. Morgan Energy, Power & Renewables Conference Date: June 17-18, 2024 Location: InterContinental Hotel | New York, New York...

Curtiss-Wright Corporation today announced that Lynn M. Bamford, Chair and Chief Executive Officer, and K. Christopher Farkas, Vice President and Chief Financial Officer, will participate in two upcoming investor conferences on June 4-6, 2024:...

Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that it will present new data related to its DecisionDx-Melanoma and DecisionDx-UM tests at the 2024 American Society of Clinical...

Invitation Homes Inc. ("Invitation Homes" or the "Company") today announced that members of the Company's management team will participate in a roundtable discussion during Nareit's REITweek 2024 Investor Conference on Tuesday, June 4, at 11:00 a.m....

Travel + Leisure Co. announced today that Michael D. Brown, President and Chief Executive Officer, will participate in a fireside chat session at the Morgan Stanley 2nd Annual Travel & Leisure Conference on Tuesday, June 4, 2024 at 1:15 p.m. EDT....

Ryan Specialty Holdings, Inc. ("Ryan Specialty"), a leading international specialty insurance firm, today announced that its Founder, Chairman and Chief Executive Officer, Patrick G. Ryan, its President, Timothy W. Turner, its Chief Financial...

Caesarstone Ltd. , a leading developer and manufacturer of high-quality engineered surfaces, today announced that Yos Shiran, CEO, and Nahum Trost, CFO, will attend the Stifel 2024 Cross Sector Insight Conference in Boston, MA on Tuesday, June 4,...

Acadia Realty Trust ("Acadia" or the "Company") today announced that it will participate in NAREIT's REITweek®: 2024 Investor Conference. NAREIT REITweek®: 2024 Investor Conference Acadia will participate in NAREIT's REITweek®: 2024 Investor...